JP2001507677A5 - - Google Patents

Download PDF

Info

Publication number
JP2001507677A5
JP2001507677A5 JP1998524896A JP52489698A JP2001507677A5 JP 2001507677 A5 JP2001507677 A5 JP 2001507677A5 JP 1998524896 A JP1998524896 A JP 1998524896A JP 52489698 A JP52489698 A JP 52489698A JP 2001507677 A5 JP2001507677 A5 JP 2001507677A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998524896A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001507677A (ja
Filing date
Publication date
Priority claimed from US08/757,024 external-priority patent/US6025339A/en
Application filed filed Critical
Publication of JP2001507677A publication Critical patent/JP2001507677A/ja
Publication of JP2001507677A5 publication Critical patent/JP2001507677A5/ja
Ceased legal-status Critical Current

Links

JP52489698A 1996-11-26 1997-11-26 呼吸器疾患および肺の炎症に関連する疾患および状態のための薬剤ならびに治療法 Ceased JP2001507677A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/757,024 1996-11-26
US08/757,024 US6025339A (en) 1995-06-07 1996-11-26 Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
PCT/US1997/022017 WO1998023294A1 (en) 1996-11-26 1997-11-26 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation

Publications (2)

Publication Number Publication Date
JP2001507677A JP2001507677A (ja) 2001-06-12
JP2001507677A5 true JP2001507677A5 (enExample) 2004-11-25

Family

ID=25046042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52489698A Ceased JP2001507677A (ja) 1996-11-26 1997-11-26 呼吸器疾患および肺の炎症に関連する疾患および状態のための薬剤ならびに治療法

Country Status (7)

Country Link
US (1) US6025339A (enExample)
EP (1) EP0946201A4 (enExample)
JP (1) JP2001507677A (enExample)
CN (1) CN1247473A (enExample)
AU (1) AU5368898A (enExample)
CA (1) CA2272900A1 (enExample)
WO (1) WO1998023294A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935675B1 (en) * 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) * 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US7034007B1 (en) 1995-06-07 2006-04-25 East Carolina University Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depletion
US6825174B2 (en) 1995-06-07 2004-11-30 East Carolina University Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
CA2304312A1 (en) * 1997-09-17 1999-03-25 East Carolina University Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
US20040186071A1 (en) * 1998-04-13 2004-09-23 Bennett C. Frank Antisense modulation of CD40 expression
ATE305507T1 (de) * 1998-05-14 2005-10-15 Coley Pharm Gmbh Verfahren zur regulierung der hematopoiese mit hilfe von cpg oligonukleotide
EP1011608A4 (en) * 1998-06-08 2002-05-15 Epigenesis Pharmaceuticals Inc COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF HEART AND NEUTRAL FAILURE OR DAMAGE RELATED TO ISCHEMIA, ENDOTOXIN RELEASE, ARDS OR CALLED BY THE ADDITION OF SPECIFIC MEDICINES
JP2002528412A (ja) * 1998-10-27 2002-09-03 イェール ユニバーシティ 分泌通路を通る不適当に折り畳まれたタンパク質のコンダクタンス
US6627215B1 (en) 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
US6211162B1 (en) * 1998-12-30 2001-04-03 Oligos Etc. Inc. Pulmonary delivery of protonated/acidified nucleic acids
US7868162B2 (en) 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
BR0006019A (pt) * 1999-04-06 2001-03-13 Univ East Carolina Oligonucleotìdeo de anti-sentido de adenosina baixo, composições, kit & método para tratamento de distúrbios de vias aéreas associados com broncoconstricção, inflamação pulmonar, alergia(s) & depleção de surfactante
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
EP1386004A4 (en) * 2001-04-05 2005-02-16 Ribozyme Pharm Inc MODULATION OF GENE EXPRESSION ASSOCIATED WITH INFLAMMATORY PROLIFERATION AND GROWTH OF NEURITIES BY METHODS INVOLVING NUCLEIC ACID
JP2006512927A (ja) * 2002-12-11 2006-04-20 コーリー ファーマシューティカル グループ，インコーポレイテッド ５’ｃｐｇ核酸およびその使用方法
US20040235770A1 (en) * 2003-04-02 2004-11-25 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
JP2007506440A (ja) 2003-09-29 2007-03-22 トピジェン・ファルマスーティック・インコーポレーテッド 炎症性症状を含む疾患を治療するための、オリゴヌクレオチド組成物および方法
TWI235440B (en) * 2004-03-31 2005-07-01 Advanced Semiconductor Eng Method for making leadless semiconductor package
CN101087623B (zh) * 2004-10-29 2012-09-26 托皮根药品公司 用于治疗变态反应和肿瘤细胞增殖的反义寡核苷酸
CA2603976A1 (en) * 2005-04-08 2006-10-19 Coley Pharmaceutical Group, Inc. Methods for treating infectious disease exacerbated asthma
JP2009537118A (ja) * 2006-05-19 2009-10-29 トピジェン・ファーマシューティカルズ・インコーポレーテッド ホスホジエステラーゼの発現に影響するオリゴヌクレオチド
EP2222851B1 (en) 2007-11-20 2017-06-28 Ionis Pharmaceuticals, Inc. Modulation of cd40 expression
WO2009117418A2 (en) 2008-03-17 2009-09-24 The Board Of Regents Of The University Of Texas System Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
CA2724179A1 (en) 2008-05-15 2009-11-19 Topigen Pharmaceuticals Inc. Oligonucleotides for treating inflammation and neoplastic cell proliferation
US11401303B2 (en) * 2020-06-15 2022-08-02 Taian City Qihang Biotechnology Co. Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225326A (en) * 1988-08-31 1993-07-06 Research Development Foundation One step in situ hybridization assay
US5245022A (en) * 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
GB2264948B (en) * 1992-03-13 1996-10-16 Merck & Co Inc Human adenosine receptors
EP0644935A1 (en) * 1992-06-12 1995-03-29 Garvan Institute Of Medical Research DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS
US5320962A (en) * 1992-07-22 1994-06-14 Duke University DNA encoding the human A1 adenosine receptor
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA
US5994315A (en) * 1995-06-07 1999-11-30 East Carolina University Low adenosine agent, composition, kit and method for treatment of airway disease
US6040296A (en) * 1995-06-07 2000-03-21 East Carolina University Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2002513378A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000510460A5 (enExample)
JP2000500055A5 (enExample)
JP2001500475A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000510560A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000508668A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2001502367A5 (enExample)
JP2000516579A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)
JP2001507677A5 (enExample)